Chronic Inhibition of PDE5 Limits Pro-Inflammatory Monocyte-Macrophage Polarization in Streptozotocin-Induced Diabetic Mice (original) (raw)

PDE5 Inhibition Stimulates Tie2-Expressing Monocytes and Angiopoietin-1 Restoring Angiogenic Homeostasis in Diabetes

Fabio Naro

The Journal of Clinical Endocrinology and Metabolism, 2019

View PDFchevron_right

Diabetes and inflammation: Fundamental aspects and clinical implications

Cyril John C. Garcia

Diabetes & Metabolism, 2010

View PDFchevron_right

Endothelium, inflammation, and diabetes

Paresh Dandona

Current Diabetes Reports, 2002

View PDFchevron_right

The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives

Georgia Vogiatzi

European Cardiology Review, 2019

View PDFchevron_right

Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1

Charles Serhan

Proceedings of the National Academy of Sciences, 2012

View PDFchevron_right

Alternatively Activated Macrophages in Types 1 and 2 Diabetes

Luis Terrazas

Mediators of Inflammation, 2012

View PDFchevron_right

Proinflammatory and atherogenic activity of monocytes in Type 2 diabetes

Tadeusz Dobosz

Journal of Diabetes and its Complications, 2010

View PDFchevron_right

Title : Role of Inflammatory Mediators in Diabetes and Cardiovascular Diseases

Dr. Ramu Adela

2015

View PDFchevron_right

Monocyte and macrophage foam cells in diabetes-accelerated atherosclerosis

Jocelyn Cervantes

Frontiers in Cardiovascular Medicine, 2023

View PDFchevron_right

Inflammatory Process in Type 2 Diabetes: The Role of Cytokines

Chris Kalofoutis, Christina Piperi

Annals of the New York Academy of Sciences, 2006

View PDFchevron_right

Tumor Necrosis Factor- Does Not Mediate Diabetes-Induced Vascular Inflammation in Mice

Jan Nilsson

Arteriosclerosis, Thrombosis, and Vascular Biology, 2009

View PDFchevron_right

Macrophage inflammatory state in Type 1 diabetes: triggered by NLRP3/iNOS pathway and attenuated by docosahexaenoic acid

Rui Curi

Clinical Science, 2021

View PDFchevron_right

Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type II-like db/db mice

R. Seljelid

Diabetes, 2000

View PDFchevron_right

Inflammation in the pathogenesis of microvascular complications in diabetes

Dung Nguyen

Frontiers in endocrinology, 2012

View PDFchevron_right

Mechanisms responsible for enhanced inflammatory response to ischemia-reperfusion in diabetes

D. Neil Granger

American Journal of Physiology-Heart and Circulatory Physiology, 1998

View PDFchevron_right

Macrophage function in alloxan diabetic mice: expression of adhesion molecules, generation of monokines and oxygen and NO radicals

Krzysztof Bryniarski

Clinical and Experimental Immunology, 1998

View PDFchevron_right

Diabetes-induced alteration of F4/80+ macrophages: a study in mice with streptozotocin-induced diabetes for a long term

Wenjun Ding

Journal of Molecular Medicine, 2008

View PDFchevron_right

Modification of adverse inflammation is required to cure new-onset type 1 diabetic hosts

Nicolas Degauque

Proceedings of the National Academy of Sciences, 2007

View PDFchevron_right

Endothelial Dysfunction in Type 2 Diabetes: Targeting Inflammation

Fernanda Carrilho

Endothelial Dysfunction - Old Concepts and New Challenges, 2018

View PDFchevron_right

IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat

Bernard Portha

Proceedings of the National Academy of Sciences, 2009

View PDFchevron_right

The role of inflammation and macrophage accumulation in the development of obesity-induced type 2 diabetes mellitus and the possible therapeutic effects of long- …

Fiona McGillicuddy

Proceedings of the …, 2010

View PDFchevron_right

Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice

David Nikolic-paterson

Kidney International, 2006

View PDFchevron_right

Macrophage foam cell formation is augmented in serum from patients with diabetic angiopathy

Fusanori Nishimura

Diabetes Research and Clinical Practice, 2010

View PDFchevron_right

Diabetes, inflammation, proinflammatory cytokines, and diabetic nephropathy

Juan Pablo Manrique Navarro

TheScientificWorldJournal, 2006

View PDFchevron_right

Macrophages in mouse type 2 diabetic nephropathy: Correlation with diabetic state and progressive renal injury

David Nikolic-paterson

Kidney International, 2004

View PDFchevron_right

Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy

Alberto Martínez-castelao

World journal of diabetes, 2012

View PDFchevron_right

Neutrophils and monocytes as potentially important sources of proinflammatory cytokines in diabetes

Mauro Marrocos

Clinical and Experimental Immunology, 2006

View PDFchevron_right

The role of immune and inflammatory processes in the development of macrovascular disease in diabetes

Maria Lopes-virella

Frontiers in Bioscience, 2003

View PDFchevron_right

Evidence of Increased Inflammation and Monocytic Activity in Patients with Type 1 Diabetes: plausible role in Microvascular Complications

Sridevi Devaraj

2007

View PDFchevron_right

Aldose Reductase Mediates NLRP3 Inflammasome- Initiated Innate Immune Response in Hyperglycemia-Induced Thp1 Monocytes and Male Mice

Pabitra Bikash Pal

Endocrinology

View PDFchevron_right

Role of Inflammation in the Pathogenesis of Diabetic Nephropathy

International Journal of Diabetology and Vascular Disease Research (IJDVR)

View PDFchevron_right

Macrophage Cyclooxygenase-2 Protects Against Development of Diabetic Nephropathy

Raymond Harris

Diabetes, 2016

View PDFchevron_right